Hyperbaric oxygen therapy for children with autism spectrum disorder

Area of Science:

• Neurology
• Pediatrics
• Biomedical Engineering

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with diverse genetic and environmental influences.
• Parents frequently inquire about alternative therapies, such as hyperbaric oxygen therapy (HBOT), to manage ASD symptoms.
• Commercial advertising has previously suggested positive outcomes for HBOT in children with ASD.

Purpose of the Study:

• To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for children diagnosed with autism spectrum disorder (ASD).
• To provide evidence-based guidance for clinicians considering recommending HBOT for pediatric ASD patients.

Main Methods:

• Systematic review of existing literature, including case series and randomized controlled trials (RCTs) investigating HBOT for ASD.
• Analysis of reported outcomes and effectiveness data from published studies.

Main Results:

• The majority of evidence from case series and RCTs does not support the use of HBOT for improving outcomes in children with ASD.
• One randomized controlled trial reported positive findings, but these results have not been independently replicated.

Conclusions:

• Based on current scientific evidence, hyperbaric oxygen therapy (HBOT) is not a recommended treatment for children with autism spectrum disorder (ASD).
• Further rigorous and reproducible research is needed to definitively establish or refute any potential benefits of HBOT for ASD.